Biotechnology Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Rare Disease-Focused Rallybio Inks Development Pact With Johnson & Johnson, Stock Shoots Higher – Rallybio (NASDAQ:RLYB), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Why Is 2seventy bio Stock Trading Higher On Monday? – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ), 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology FDA To Review Two Cell Therapies For Multiple Myeloma This Week – Johnson & Johnson And Bristol-Myers – Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Golden Cross Alert: Johnson & Johnson Shines With Ambrx Deal, Bullish Technical Signal – Johnson & Johnson (NYSE:JNJ) Read more
